ImmunAdd
Latest round
- Series A
Last raised
- Jun 2025
Total raised
- $15M
Investors
- 1
About ImmunAdd
Founded in 2022, ImmunAdd Inc. is dedicated to developing novel vaccine adjuvants. The company was founded by its CEO Dr. Pi-Hui Liang. ImmunAdd, Inc. specializes in the development of next-generation vaccine adjuvants, particularly its core product, IA-05, a truncated analogue of QS-21. IA-05 enhances immune responses and improves tolerability and stability when used with various antigens. The company targets biopharmaceutical firms and research institutions globally, focusing on markets in North America, Europe, and Asia, aiming for collaborations that leverage its advanced adjuvant technology for enhanced vaccine formulations. ImmunAdd's revenue generation strategy relies on partnerships with biopharmaceutical companies and research institutions through B2B transactions, where it licenses its proprietary adjuvant technology. This involves upfront licensing fees along with milestone payments or royalties based on future product sales, tailored to each agreement. The company aims to expand its market presence in North America, Europe, and Asia, seeking collaborations that will enhance its growth in these regions. The anticipated advancements will support its goal of developing innovative vaccine solutions for global health challenges.
Who invested in ImmunAdd
1 investor across 2 rounds
See all investors in ImmunAdd
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ImmunAdd
Who invested in ImmunAdd?
ImmunAdd has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmunAdd raised?
ImmunAdd has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ImmunAdd last raise money?
ImmunAdd's most recent round on record is a Series A, in Jun 2025.
What does ImmunAdd do?
ImmunAdd is a pharmaceuticals company.
Where is ImmunAdd headquartered?
ImmunAdd is headquartered in Taipei, Taiwan - China.
Which VCs invest in companies like ImmunAdd?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at ImmunAdd's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like ImmunAdd? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.